News in the Life Sciences Industry

BOONE, N.C., Aug. 21, 2019 /PRNewswire/ -- Pneuma Respiratory, Inc. announced that Board member Jay Morgan has assumed the position of Chairman of the Board. Pneuma's previous Chairman, Walt Robb, will remain a member of the Board of Directors.

GALVESTON, Texas, Aug. 21, 2019 /PRNewswire/ -- Chrysalis BioTherapeutics, Inc. today announced that the US Food and Drug Administration (FDA) Office of Orphan Product Development and the European Medicines Agency (EMA) have granted Orphan Drug Designation (ODD) to the company's lead compound,... Read more ››

NEW YORK, Aug. 21, 2019 /PRNewswire/ -- Partnership for Drug-Free Kids has launched two campaigns that examine the impact... Read more ››

DUBLIN, Aug. 21, 2019 /PRNewswire/ -- The Read more ››

PALO ALTO, Calif., Aug. 21, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it has successfully completed its asset purchase of the Boston Scientific portfolio of drug-loadable microsphere and bland embolic bead products for treating arteriovenous malformations and hypervascular tumors.... Read more ››

ALAMEDA, Calif., Aug. 21, 2019 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the 2019 Wells Fargo Healthcare Conference in Boston, MA on Wednesday, September 4, 2019.

CHICAGO, Aug. 21, 2019 /PRNewswire/ -- Hillrom (NYSE: HRC) today announced that it will present at the 17(th) Annual Morgan Stanley Global Healthcare Conference on Monday, September 9, 2019, in New York. John Groetelaars, Hillrom's president and chief executive officer, is scheduled to present... Read more ››

PALO ALTO, Calif., Aug. 21, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced that Phil Febbo, MD, chief medical officer (CMO) at Illumina has been appointed to the Varian Board of Directors, effective August 16, 2019.

Decision Drives Anti-Aging Market

FRANKLIN LAKES, N.J., Aug. 21, 2019 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the following upcoming investor healthcare conferences:

LOS ANGELES, Aug. 21, 2019 /PRNewswire/ -- Hologenix, LLC, the inventor of Celliant® technology, announced today the expansion of its executive team and the relocation of its headquarters back to Los Angeles.

PHOENIX, Aug. 21, 2019 /PRNewswire/ -- Dr. Michael Wilmink of OrthoArizona is leading the minimally invasive approach of how hip replacements are done. Hip replacements are notorious for being complex with an overnight stay at the hospital. The surgeons at Read more ››

MUNICH and BASKING RIDGE, N.J., Aug. 21, 2019 /PRNewswire/ -- Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that updated results and new translational research data from two phase 1 studies evaluating investigational antibody drug conjugates (ADCs) U3-1402 and DS-1062... Read more ››

PLYMOUTH, Minn., Aug. 21, 2019 /PRNewswire/ -- The Hazelden Betty Ford Foundation announced today that its renowned Read more ››